My specialty is nuclear medicine molecular imaging and radiopharmaceutical chemistry. So far, I have been working on development of some imaging probes to visualize the characteristic of the tumor at the National Cancer Center, and those studies are now leading to the creation of novel radio-theranostics.

In nuclear medicine imaging procedures, radioactive agents that are called probes or radiopharmaceuticals, are introduced into the living body, where it gets incorporated in a specific tissue, organ or process and is then detected by an external device, or specially designed cameras, to provide information on organ function and cellular activity. Therefore, the development of nuclear medicine and molecular imaging technologies has been facilitated by associated development of imaging instruments as well as imaging agents. In Kavli IPMU, my colleagues have been developing new generation detectors of hard X-ray and gamma-ray astrophysics, and now they are applying them to the nuclear medicine field. It should have the great potential to be a breakthrough in this field. I desire to exploit innovative nuclear medicine technique with them in Kavli IPMU.